miR-29cb2 promotes angiogenesis and osteogenesis by inhibiting HIF-3α in bone

Liping Ouyang,Yingxiao Sun,Dan Lv,Xiaochun Peng,Xiaoming Liu,Lei Ci,Guoning Zhang,Bo Yuan,Ling Li,Jian Fei,Jun Ma,Xuanyong Liu,Yun Liao

DOI: https://doi.org/10.1016/j.isci.2021.103604

IF: 5.8

2022-01-01

iScience

Abstract:Coordination between osteogenesis and angiogenesis is required for bone homeostasis. Here, we show that miR-29cb2 is a bone-specific miRNA and plays critical roles on angiogenesis-osteogenesis coupling during bone remodeling. Mice with deletion of miR-29cb2 exhibit osteopenic phenotypes and osteoblast impairment, accompanied by pronounced decreases in specific H vessels. The decrease in bone miR-29cb2 was associated with pathological ovariectomy stimuli. Mechanistically, hypoxia-inducible factor (HIF)-3α, as a target for miR-29cb2, inhibits HIF-1α activity by competitively bonding with HIF-1β. Notably, miR-29cb2 in peripheral blood (PB) nearly is undetectable in sham and significantly increases in ovariectomy mice. Further evaluation from osteoporosis patients demonstrates similar signatures. ROC analysis shows miR-29cb2 in PB has higher sensitivity and specificity for diagnosing osteoporosis when compared with four clinical biomarkers. Collectively, these findings reveal that miR-29cb2 is essential for bone remodeling by inhibiting HIF-3α and elevated bone-specific miR-29cb2 in PB, which may be a promising biomarker for bone loss.

multidisciplinary sciences